Related Experiment Video
Updated: Jan 12, 2026

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
Artificial intelligence applications in inherited retinal dystrophies
Peter Kiraly1,2, M Dominik Fischer3,4,5
1Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. peter.kiraly20@gmail.com.
Artificial intelligence (AI) shows promise for diagnosing inherited retinal dystrophies (IRDs) by predicting variants and segmenting retinal layers. Overcoming challenges like data standardization and the "black-box" problem is key to AI
Area of Science:
- Ophthalmology
- Genetics
- Medical Artificial Intelligence
Background:
- Inherited retinal dystrophies (IRDs) are a leading cause of blindness with significant genetic and phenotypic variability.
- Current molecular diagnostic pathways for IRDs are often lengthy, costly, and resource-limited.
- Artificial intelligence (AI) presents a transformative potential for improving IRD diagnosis and management.
Purpose of the Study:
- To review current literature on AI-driven approaches for diagnosing inherited retinal dystrophies.
- To highlight the potential applications and existing challenges of AI in the field of IRDs.
Main Methods:
- A comprehensive literature review of AI applications in inherited retinal dystrophies was conducted.
- Key AI-driven approaches and their reported outcomes were analyzed.
Main Results:
- AI models demonstrate efficacy in predicting disease-causing variants, differentiating phenotypically similar IRDs, and segmenting retinal layers.
- Potential future applications include genetic counseling, progression prediction, and personalized treatment outcome prediction.
- Significant barriers to clinical adoption include lack of standardization, data variability, imaging inconsistencies, and AI's "black-box" nature.
Conclusions:
- AI holds substantial promise for revolutionizing IRD diagnosis and management.
- Addressing challenges related to data, standardization, and AI transparency is critical for widespread clinical adoption.
- Continued research and interdisciplinary collaboration are essential to harness AI's full potential in IRDs.
More Related Videos
09:47Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
12:56Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017